RESEARCH ARTICLE


Binding Properties of CD94 to Sulfated Glycans and α2,3-NeuAc-Containing Glycoproteins and Mutagenesis Analysis



Koji Higai*, Ayumi Itoh, Yuzo Imaizumi, Chiho Suzuki, Xin Xin, Yutaro Azuma, Kojiro Matsumoto
Department of Clinical Chemistry, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi, Chiba 247-8510, Japan


Article Metrics

CrossRef Citations:
1
Total Statistics:

Full-Text HTML Views: 898
Abstract HTML Views: 2274
PDF Downloads: 789
Total Views/Downloads: 3961
Unique Statistics:

Full-Text HTML Views: 516
Abstract HTML Views: 1319
PDF Downloads: 548
Total Views/Downloads: 2383



Creative Commons License
© 2011 Higai et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Department of Clinical Chemistry, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi, Chiba 247-8510, Japan; Tel: +81-474-72-1481; Fax: +81-474-1485; E-mail: koji@phar.toho-u.ac.jp


Abstract

Killer lectin-like receptor CD94 on natural killer cells can bind to HLA-E, α2,3-NeuAc-containing glycoproteins, and heparin. Using the glutathione-S-transferase-fused CD94 (rGST-CD94), we investigated its binding to plates coated with α2,3-NeuAc-containing transferrin secreted by HepG2 cells (HepTF) and sulfate-containing glycanconjugated BSA. rGST-CD94 bound directly to several glycans with similar high affinities: rGST-CD94 bound to heparin- BSA, heparan sulfate-BSA, fucoidan-BSA, λ-carrageenan-BSA, and HepTF with Kd values of 36 nM, 141 nM, 36 nM, 92 nM and 84 nM, respectively. Different mutants of rGST-CD94 were generated by site-directed mutagenesis. Mutants N160A and C166G had reduced binding to sulfated glycans and HepTF, also F114A, L162A, D163A, and E164A showed reduced binding to sulfated glycans with some variability. These results indicated that CD94 interacts with sulfated glycans and α2,3-NeuAc-containing glycoproteins suggesting that glycan binding sites in CD94 partially overlap with the HLA-E binding sites to modulate natural killer cell-dependent cytotoxicity.

Keywords: CD94, killer lectin-like receptors, heparin, sialy Lewis X, mutagenesis.